Freedom Investment Management’s TherapeuticsMD TXMD Stock Holding History

Freedom Investment Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-208	Closed	-$4K	–	944
2021 Q4	$4K	Sell	208 -5	-2%	-$150	﹤0.01%	860
2021 Q3	$8K	Sell	213 -91	-30%	-$4.04K	﹤0.01%	810
2021 Q2	$18K	Sell	304 -31	-9%	-$1.88K	﹤0.01%	868
2021 Q1	$22K	Sell	335 -13	-4%	-$1.02K	﹤0.01%	835
2020 Q4	$21K	Buy	+348	New	+$23.8K	﹤0.01%	612
2018 Q4	–	Sell	-261	Closed	-$83K	–	896
2018 Q3	$83K	Sell	261 -3	-1%	-$919	0.01%	889
2018 Q2	$83K	Sell	264 -19	-7%	-$5.8K	0.01%	939
2018 Q1	$69K	Sell	283 -5	-2%	-$1.4K	﹤0.01%	1097
2017 Q4	$87K	Sell	288 -9	-3%	-$2.5K	﹤0.01%	1107
2017 Q3	$79K	Buy	297 +27	+10%	+$7.81K	﹤0.01%	1077
2017 Q2	$71K	Buy	270 +4	+2%	+$1K	﹤0.01%	1044
2017 Q1	$96K	Buy	266 +39	+17%	+$12.1K	0.01%	1025
2016 Q4	$66K	Buy	+227	New	+$70.3K	﹤0.01%	961

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Freedom Investment Management's TXMD Position: Q1 2022 in Review

Freedom Investment Management sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 208 shares — an estimated $4K sold.

Freedom Investment Management first reported a position in TXMD in Q4 2016 and held it in 13 quarters. The position peaked at $96K in Q1 2017. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

Freedom Investment Management reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
Freedom Investment Management sold 208 TherapeuticsMD shares in Q1 2022, an estimated $4K.
Freedom Investment Management first reported a position in TherapeuticsMD in Q4 2016 and held it in 13 quarters.
Freedom Investment Management's TherapeuticsMD position peaked at $96K in Q1 2017.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on Freedom Investment Management's 13F filing for Q1 2022, filed 16 May 2022.